Press release
Albumin (as Excipient) Market to 2018 - 2026: Albumedix A/S (Novozyme A/S), Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, Grifols International, S.A., HiMedia Laboratories Pvt. Ltd
Researchmoz added Most up-to-date research on "Albumin (as Excipient) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026" to its huge collection of research reports.Global Albumin (as Excipient) Market: Overview
This report analyzes the global albumin (as excipient) market in terms of its current and future business prospects. Grant of regulatory approvals and subsequent launch of albumin-based products, increasing participation from the pharmaceutical industry in the development and manufacturing of biopharmaceuticals, along with rise in research & development expenditure and increase in consumption of albumin are the key factors driving the growth of the global albumin (as excipient) market. Albumin serves as an important ingredient for formulated proteins and as a component of culture media and other biotech products, ultimately acting as a multifunctional excipient. Use of a well-characterized multifunctional excipient eliminates the time consumed during characterization of each excipient for different functions. This reduces the associated cost, shortens the registration process, and creates a faster route toward the market. Other factors, such as, decrease in issues with variability in quality, lower lot-to-lot and supplier-to-supplier variation, and reduction in the time involved in formulation optimization also drive the demand for albumin as excipient.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=E&repid=244197
This report on albumin (as excipient) market comprises an elaborate executive summary, which includes a market snapshot, providing information on the various segments of the market. It also provides information and data analysis of the global market with respect to its segments based on product, application, end-user and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section of the report. In addition, it comprises competitive matrix and company profiles with business overview to understand the competition in the market. The section also provides market attractiveness analysis, by geography, and market share analysis, in terms of key players, thus presenting a thorough analysis of the overall competitive scenario in the albumin (as excipient) market.
Global Albumin (as Excipient) Market: Key Segments
In terms of product, the global albumin (as excipient) market has been segmented into human serum albumin and recombinant albumin. Based on application, the global market has been divided into human serum albumin applications and recombinant albumin applications. The human serum albumin application segment has further been classified into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. The recombinant albumin segment has further been bifurcated into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. Market size and forecast for each of these segments have been provided in terms of US$ Mn for the period of 2016 to 2026, along with their respective CAGRs, for the forecast period of 2018 to 2026, considering 2017 as the base year.
Global Albumin (as Excipient) Market: Regional Outlook
Geographically, the global albumin (as excipient) market has been categorized into four major regions and key countries in the respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia, and Rest of Asia Pacific), Rest of the World (Brazil, Mexico, South Africa, Saudi Arabia). Market size and forecast for each of these regions and countries have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period of 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario of the albumin (as excipient) market in these regions.
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/albumin-excipient-market-types-human-serum-albumin-bovine-serum-albumin-and-recombinant-albumin-applications-drug-formulation-and-drug-delivery-vaccines-and-component-of-media-global-industry-analysis-size-share-volume-growth-trends-a-report.html/toc
Companies Profiled in the Report
The report also profiles major players operating in the global albumin (as excipient) market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the market are Albumedix A/S (Novozyme A/S), Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, Grifols International, S.A, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte Ltd, Octapharma AG, RayBiotech, Inc., SeraCare Life Sciences, and Sigma-Aldrich Co. (Merck KGaA).
The global albumin (as excipient) market has been segmented as given below:
Product
Human Serum Albumin
Recombinant Albumin
Application
Human Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
Recombinant Albumin Applications
Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
End-user
Pharmaceutical & Biotechnology Industry
Research Institutes
Others
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=244197
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Albumin (as Excipient) Market to 2018 - 2026: Albumedix A/S (Novozyme A/S), Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, Grifols International, S.A., HiMedia Laboratories Pvt. Ltd here
News-ID: 1467629 • Views: …
More Releases from Albumin (as Excipient) Market

Global Albumin (as Excipient) Market to Reach US$ 1200 Mn by 2026 : Albumedix A/ …
Researchmoz added Most up-to-date research on "Albumin (as Excipient) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026" to its huge collection of research reports. An insight on the important factors and trends influencing the market.
Global Albumin (as Excipient) Market: Overview
This report analyzes the global albumin (as excipient) market in terms of its current and future business prospects. Grant of regulatory approvals and subsequent launch of albumin-based…
More Releases for Excipient
Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of…
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…